More on TGTX
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $54.40 |
|
|||
| Open | $54.00 | ||||
| 52 Wk High | $14.87 | ||||
| 52 Wk Low | $4.90 | ||||
| Day High | $55.52 | ||||
| Day Low | $52.70 | ||||
| P/E | N/A | ||||
| EPS | $-0.67 | ||||
| Volume | 1,800,928 | ||||
- Form 4 TG THERAPEUTICS, INC. For: Jun 11 Filed by: Lonial Sagar
- Form 4 TG THERAPEUTICS, INC. For: Jun 11 Filed by: HUME DANIEL
- Form 4 TG THERAPEUTICS, INC. For: Jun 11 Filed by: Hoberman Kenneth
- Form 4 TG THERAPEUTICS, INC. For: Jun 11 Filed by: Echelard Yann
- Form 4 TG THERAPEUTICS, INC. For: Jun 11 Filed by: Charney Laurence N
- Form 8-K TG THERAPEUTICS, INC. For: Jun 11
- TG Therapeutics reports positive phase 1 data for BRIUMVI in myasthenia gravis
- TG Therapeutics Announces Positive Topline Phase 1 Data for Subcutaneous BRIUMVI in Patients with Myasthenia Gravis and Initiation of Potential Registration Directed Randomized Phase 2 Trial
- Form 8-K TG THERAPEUTICS, INC. For: Jun 03
- TG Therapeutics reports positive Phase 1 subcutaneous BRIUMVI trial results
Entities mentioned with TGTX
- Definitive Agreement | View Related Stories »
- FDA | View Related Stories »
- Twitter | View Related Stories »
- Earnings | View Related Stories »
- PDUFA | View Related Stories »
- AdCom | View Related Stories »
- 13G | View Related Stories »
- Maynard Um | View Related Stories »
- Show More...
